Literature DB >> 11791184

Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.

Cynthia C Sprenger1, Mary E Vail, Karen Evans, Jerry Simurdak, Stephen R Plymate.   

Abstract

In the present study, we examined the effects of over-expression of the potential tumor suppressor gene IGFBP-rP1/mac25 on cell-cycle kinetics in prostate cancer cells. The majority of the high expressing IGFBP-rP1/mac25 cell population was located in the G1 and sub-G0/G1 peaks; synchronizing cells in G2/M with nocodazole demonstrated the high expressing IGFBP-rP1/mac25 clones were delayed in the G1 phase of the cell cycle. Unscheduled expression of cyclin A in the sub-G0/G1 peak occurred in the IGFBP-rP1/mac25 clones. Immunoblots showed decreased cyclin D1 and p21 and increased cyclin E, p16, and p27 in the high expressing IGFBP-rP1/mac25 clones compared to the control cells. Cyclin D1/cdk-4,6 and cyclin E/cdk-2 kinase activities decreased but cyclin A/cdk-2 kinase activity increased for the high expressing IGFBP-rP1/mac25 clones compared to control cells. A pRb immunoprecipitation demonstrated more binding of E2F-1 to pRb in the high expressing IGFBP-rP1/mac25 clones than in control cells. Finally, cell senescence, as assessed by senescence-associated beta-galactosidase, demonstrated significantly more staining in the IGFBP-rP1/mac25 cells than control cells. These results suggest that IGFBP-rP1/mac25 alters the cell cycle kinetics of the M12 prostate cell line by delaying the cells in the G1 phase of the cell cycle. In addition, the appearance of cyclin A in the sub-G0/G1 phase of the cell cycle and the increased kinase activity of cyclin A/cdk-2 in the IGFBP-rP1/mac25 clones suggests that cyclin A is associated with the apoptotic cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11791184     DOI: 10.1038/sj.onc.1205021

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II.

Authors:  Jun-Feng Kou; Chen Qian; Jin-Quan Wang; Xiang Chen; Li-Li Wang; Hui Chao; Liang-Nian Ji
Journal:  J Biol Inorg Chem       Date:  2011-08-21       Impact factor: 3.358

2.  Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma.

Authors:  Dong Chen; Byoung Kwon Yoo; Prasanna Kumar Santhekadur; Rachel Gredler; Sujit K Bhutia; Swadesh K Das; Christine Fuller; Zao-zhong Su; Paul B Fisher; Devanand Sarkar
Journal:  Clin Cancer Res       Date:  2011-09-09       Impact factor: 12.531

Review 3.  Therapy-induced senescence in cancer.

Authors:  Jonathan A Ewald; Joshua A Desotelle; George Wilding; David F Jarrard
Journal:  J Natl Cancer Inst       Date:  2010-09-21       Impact factor: 13.506

4.  HSP60, a protein downregulated by IGFBP7 in colorectal carcinoma.

Authors:  Wenjing Ruan; Yinghong Wang; Yu Ma; Xiaoming Xing; Jie Lin; Jing Cui; Maode Lai
Journal:  J Exp Clin Cancer Res       Date:  2010-04-30

5.  IGFBP-rP1, a potential molecule associated with colon cancer differentiation.

Authors:  Wenjing Ruan; Shuzhen Zhu; Haibing Wang; Fangying Xu; Hong Deng; Yu Ma; Maode Lai
Journal:  Mol Cancer       Date:  2010-10-26       Impact factor: 27.401

6.  Senescence-induced alterations of laminin chain expression modulate tumorigenicity of prostate cancer cells.

Authors:  Cynthia C T Sprenger; Rolf H Drivdahl; Lillie B Woodke; Daniel Eyman; May J Reed; William G Carter; Stephen R Plymate
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

Review 7.  Senescence-messaging secretome: SMS-ing cellular stress.

Authors:  Thomas Kuilman; Daniel S Peeper
Journal:  Nat Rev Cancer       Date:  2009-01-09       Impact factor: 60.716

8.  Decreased expression of IGFBP7 was a poor prognosis predictor for gastric cancer patients.

Authors:  Long Liu; Zhihui Yang; Weixing Zhang; Bing Yan; Qunhao Gu; Jianpeng Jiao; Xiaoqiang Yue
Journal:  Tumour Biol       Date:  2014-06-04

9.  Invasion of normal human fibroblasts induced by v-Fos is independent of proliferation, immortalization, and the tumor suppressors p16INK4a and p53.

Authors:  Linda A Scott; J Keith Vass; E Kenneth Parkinson; David A F Gillespie; Joseph N Winnie; Bradford W Ozanne
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

10.  Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases.

Authors:  Todd E Golde; Victor M Miller
Journal:  Alzheimers Res Ther       Date:  2009-10-12       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.